Evidence map›Paper›PMID 42205984›Full record

ArticleFrontiers in nephrology2026

Use of oXiris

David Yepes Gómez, Sara Moreno-Bedoya, Sofía Lohle-Rueda, Juan Rodrigo Moreno-Restrepo, María Palacio-Muñoz, Nicolás Gómez-Correa, Andrea Sierra Ramirez, María Camila Salazar Agudelo, Esteban Villegas-Arbeláez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David Yepes GómezCritical Care Physician, Department Head, Victoriana Clinic, Intensivist, Clínica Las Américas, Medellín, Colombia.
Sara Moreno-BedoyaPostgraduate in Epidemiology, Anesthesiology resident, Faculty of Medicine, Universidad CES, Medellín, Colombia.
Sofía Lohle-RuedaMaster of Business Administration (MBA) candidate, Faculty of Medicine, Universidad del Rosario, Bogotá, Colombia.
Juan Rodrigo Moreno-RestrepoCritical Care specialist, Critical Care Unit coordinator, Clínica CES, Medellín, Colombia.
María Palacio-MuñozGeneral Practitioner, High Dependency Unit, Clínica CES, Medellín, Colombia.
Nicolás Gómez-CorreaGeneral Practitioner, High Dependency Unit, Clínica CES, Medellín, Colombia.
Andrea Sierra RamirezAnesthesiology resident, Faculty of Medicine, Universidad CES, Medellín, Colombia.
María Camila Salazar AgudeloOtorhinolaryngology resident, Faculty of Medicine, Universidad de Cartagena, Cartagena, Colombia.
Esteban Villegas-ArbeláezClinical Epidemiology, Health Research Lead, Clínica CES, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sepsis-associated acute kidney injury (SA-AKI) is common in critically ill patients and carries high short-term mortality despite timely antimicrobials and organ support. Adsorptive hemofilters such as the oXiris Methods: We performed a retrospective matched cohort study within a dynamic cohort of consecutive adults with septic shock and SA-AKI requiring CRRT in a tertiary ICU in Medellín, Colombia (November 2020 - May 2023). Exposure was the hemofilter used at CRRT initiation (oXiris Results: After matching, 81 patients were included (53 standard filters and 28 oXiris Conclusions: In adults with septic shock and SA-AKI requiring CRRT, oXiris

Indexed as

acute kidney injurycontinuous renal replacement therapycytokine adsorptionhemofilteroXirissepsisseptic shockventilator-free days

Identifiers

PMID42205984
PMCPMC13201489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.